Immuno Chromatography Technology
Access Bio’s unique Immuno Chromatography Technology (ICT) allows its products to retain highest level of accuracy and sensitivity by efficiently utilizing a nano-gold labeling method while using a minimum quantity of antibodies. Through this technology, the products have not only top-quality but also cost-effectiveness because they are manufactured using small amounts of key reagents.
Next-generation Immunochromatography Technology, ROSUS™
ROSUS™ is the next-generation immunochromatography technology, where target analytes (e.g., pathogens) are visualized with fluorescence molecules instead of nano-gold particles in order to improve signal intensity. With this innovative technology, Access Bio will commercialize RDTs that can detect a trace amount of target molecules in clinical samples that are not possible by the conventional nano-gold technology.
|Malaria RDT||Influenza TRF|
|Scrub Typhus IgM RDT||Chlamydia TRF|
|Influenza A&B RDT(Coming Soon)|
|Strep A RDT (Coming Soon)|